Advertisement
JBC

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Originally published In Press as doi:10.1074/jbc.M706176200 on August 7, 2007

J. Biol. Chem., Vol. 282, Issue 39, 28431-28440, September 28, 2007
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplemental Data
Right arrow All Versions of this Article:
282/39/28431    most recent
M706176200v1
Right arrow Submit a Letter to Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Correll, R. N.
Right arrow Articles by Andres, D. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Correll, R. N.
Right arrow Articles by Andres, D. A.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

Plasma Membrane Targeting Is Essential for Rem-mediated Ca2+ Channel Inhibition*Formula

Robert N. Correll{ddagger}, Chunyan Pang{ddagger}, Brian S. Finlin{ddagger}, Alexandria M. Dailey{ddagger}, Jonathan Satin§1, and Douglas A. Andres{ddagger}2

From the {ddagger}Departments of Molecular and Cellular Biochemistry and §Physiology, University of Kentucky College of Medicine, Lexington, Kentucky 40536-0509

The small GTPase Rem is a potent negative regulator of high voltage-activated Ca2+ channels and a known interacting partner for Ca2+ channel accessory beta subunits. The mechanism for Rem-mediated channel inhibition remains controversial, although it has been proposed that CaVbeta association is required. Previous work has shown that a C-terminal truncation of Rem (Rem-(1–265)) displays reduced in vivo binding to membrane-localized beta2a and lacks channel regulatory function. In this paper, we describe a role for the Rem C terminus in plasma membrane localization through association with phosphatidylinositol lipids. Moreover, Rem-(1–265) can associate with beta2a in vitro and beta1b in vivo, suggesting that the C terminus does not directly participate in CaVbeta association. Despite demonstrated beta1b binding, Rem-(1–265) was not capable of regulating a CaV1.2-beta1b channel complex, indicating that beta subunit binding is not sufficient for channel regulation. However, fusion of the CAAX domain from K-Ras4B or H-Ras to the Rem-(1–265) C terminus restored membrane localization and Ca2+ channel regulation, suggesting that beta binding and membrane localization are independent events required for channel inhibition.


Received for publication, July 26, 2007

* This work was supported by Public Health Service Grants HL072936 (to D. A. A.), HL074091 (to J. S.), and P20 RR20171 from the National Center for Research Resources, National Institutes of Health (NIH) (to D. A. A.), an American Diabetes Association Junior Faculty award (to B. S. F.), and an American Heart Association predoctoral fellowship and NIH Interdisciplinary Cardiovascular Training Grant T32 HL072743 (to R. N. C.). The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Formula The on-line version of this article (available at http://www.jbc.org) contains supplemental Figs. S1–S3.

1 An Established Investigator of the American Heart Association.

2 To whom correspondence should be addressed: Dept. of Molecular and Cellular Biochemistry, BBSRB Rm. B-179, University of Kentucky College of Medicine, 741 S. Limestone St., Lexington, KY 40536-0509. Tel.: 859-257-6775; Fax: 859-323-1037; E-mail: dandres{at}uky.edu.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?





HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 All ASBMB Journals   Molecular and Cellular Proteomics 
 Journal of Lipid Research   ASBMB Today 
Copyright © 2007 by the American Society for Biochemistry and Molecular Biology.
Advertisement
spacer
Advertisement
Advertisement